Zobrazeno 1 - 9
of 9
pro vyhledávání: '"C. Robbie Waites"'
Autor:
C. Robbie Waites, Jeffrey D. Moehlenkamp, Amy J. Reisinger, Lora L. Arnold, Sarah H. Tannehill-Gregg, Samuel M. Cohen, Beth E. Schilling, David A. Stock, Thomas P. Sanderson, Mark A. Dominick
Publikováno v:
Toxicologic Pathology. 37:293-305
In carcinogenicity studies with PPAR γ and α/γ agonists, urinary bladder tumors have been reported in Harlan Sprague-Dawley (HSD) and Charles River Sprague-Dawley (SD) but not Wistar (WI) rats, with urolithiasis purported to be the inciting event.
Autor:
Samuel M. Cohen, James Mitroka, Martin Cano, Mark A. Dominick, M. Randy White, C. Robbie Waites, Lora L. Arnold, Terry Van Vleet, Thomas P. Sanderson, Beth E. Schilling
Publikováno v:
Toxicological Sciences. 96:58-71
Muraglitazar, a PPARa/g dual agonist, was dosed orally to rats once daily for 13 weeks to evaluate urinary and urothelial changes of potential relevance to urinary bladder tumorigenesis. Groups of 17 young or aged rats per sex were fed a normal or 1%
Autor:
Calvert Louden, Timothy K. Hart, C. Robbie Waites, Anne M. Klinkner, William D. Kerns, Peter J. Bugelski
Publikováno v:
Journal of Histochemistry & Cytochemistry. 45:743-753
SUMMARY We introduce here a new fluorescence microscopy technique for en face analysis of the atherosclerotic fatty streaks (FS). This technique is semiquantitative and has the sensitivity and resolution to map lipids to individual cells in FS less t
Autor:
Amy J, Reisinger, Sarah H, Tannehill-Gregg, C Robbie, Waites, Mark A, Dominick, Beth E, Schilling, Todd A, Jackson
Publikováno v:
Journal of the American Association for Laboratory Animal Science : JAALAS. 48(2)
A novel therapeutic compound was found to induce bladder tumors in male rats. Given the location of the tumors and the increased amounts of calcium- and magnesium-containing solids found in the urine of treated animals, we hypothesized that tumorigen
Autor:
C. Robbie Waites, Thomas P. Sanderson, Borge M. Ulland, Mark A. Dominick, Richard W. Voelker, Daniel Minnema, Sarah H. Tannehill-Gregg, Samuel M. Cohen, Beth E. Schilling, Lora L. Arnold
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 98(1)
The carcinogenic potential of muraglitazar, a dual human peroxisome proliferator-activated receptor alpha/gamma agonist, was evaluated in 2-year studies in mice (1, 5, 20, and 40 mg/kg) and rats (1, 5, 30, and 50 mg/kg). Benign gallbladder adenomas o
Autor:
Terry R, Van Vleet, M Randy, White, Thomas P, Sanderson, Samuel M, Cohen, Martin, Cano, Lora L, Arnold, C Robbie, Waites, Beth E, Schilling, James, Mitroka, Mark A, Dominick
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 96(1)
Muraglitazar, a PPARalpha/gamma dual agonist, was dosed orally to rats once daily for 13 weeks to evaluate urinary and urothelial changes of potential relevance to urinary bladder tumorigenesis. Groups of 17 young or aged rats per sex were fed a norm
Autor:
Peter J. Bugelski, Anne M. Klinkner, C. Robbie Waites, Timothy K. Hart, Beverly E. Maleeff, William D. Kerns
Publikováno v:
Proceedings, annual meeting, Electron Microscopy Society of America. 52:352-353
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoAR) have been shown to inhibit cell growth and to affect cell differentiation in a variety of in vitro systems. The human colon carcinoma cell line CaCo-2, when grown on permeable m
Autor:
Terry R. Van Vleet, M. Randy White, Thomas P. Sanderson, Samuel M. Cohen, Martin Cano, Lora L. Arnold, C. Robbie Waites, Beth E. Schilling, James Mitroka, Mark A. Dominick
Publikováno v:
Toxicological Sciences; Mar2007, Vol. 96 Issue 1, p58-71, 14p
Autor:
Sarah H. Tannehill-Gregg, Thomas P. Sanderson, Daniel Minnema, Richard Voelker, Borge Ulland, Samuel M. Cohen, Lora L. Arnold, Beth E. Schilling, C. Robbie Waites, Mark A. Dominick
Publikováno v:
Toxicological Sciences; Jul2007, Vol. 98 Issue 1, p258-258, 1p